Advertisement

Institute for Clinical and Economic Review

Drug Pricing Value Assessment Methods in the United States: The National Pharmaceutical Council Viewpoint

August 17th, 2015|Categories: Blog, HEOR Feature|Tags: , , , , , , , , |

Swarali Tadwalkar, MPHIntern Written by Swarali Tadwalkar, MPH, Guest Blogger and Research Intern at HealthEconomics.Com Drug prices are the [...]

Good, Bad, or Indifferent on Drug Pricing: A Value Benchmark Approach for Newly Launched Drugs in the United States.

July 30th, 2015|Categories: Blog|Tags: , , , , , , , , , , , , , , |

Swarali Tadwalker, MPH Hardly a day goes by without a new article being published in the mainstream press [...]

Go to Top